» Articles » PMID: 11547739

Effect of Coinfection with GB Virus C on Survival Among Patients with HIV Infection

Overview
Journal N Engl J Med
Specialty General Medicine
Date 2001 Sep 8
PMID 11547739
Citations 110
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Previous studies have suggested that people with human immunodeficiency virus (HIV) infection who are coinfected with GB virus C (GBV-C, or hepatitis G virus) have delayed progression of HIV disease. GBV-C is related to hepatitis C virus but does not appear to cause liver disease.

Methods: We examined the effect of coinfection with GBV-C on the survival of patients with HIV infection. We also evaluated cultures of peripheral-blood mononuclear cells infected with both viruses to determine whether GBV-C infection alters replication in vitro.

Results: Of 362 HIV-infected patients, 144 (39.8 percent) had GBV-C viremia in two tests. Forty-one of the patients with GBV-C viremia (28.5 percent) died during the follow-up period, as compared with 123 of the 218 patients who tested negative for GBV-C RNA (56.4 percent; P<0.001). The mean duration of follow-up for the entire cohort was 4.1 years. In a Cox regression analysis adjusted for HIV treatment, baseline CD4+ T-cell count, age, sex, race, and mode of transmission of HIV, the mortality rate among the 218 HIV-infected patients without GBV-C coinfection was significantly higher than that among the 144 patients with GBV-C coinfection (relative risk, 3.7; 95 percent confidence interval, 2.5 to 5.4). HIV replication, as measured by the detection of p24 antigen in culture supernatants, was reproducibly inhibited in cultures of peripheral-blood mononuclear cells by GBV-C coinfection. Coinfection did not alter the surface expression of HIV cellular receptors on peripheral-blood mononuclear cells, as determined by flow cytometry.

Conclusions: GBV-C infection is common in people with HIV infection and is associated with significantly improved survival.

Citing Articles

Short-term antiretroviral therapy may not correct the dysregulations of plasma virome and cytokines induced by HIV-1 infection.

Ma Y, Zhang M, Wang Z, Cao L, Li Y, Wan Z Virulence. 2025; 16(1):2467168.

PMID: 39950859 PMC: 11866967. DOI: 10.1080/21505594.2025.2467168.


Invasions of Host-Associated Microbiome Networks.

Murall C, Abbate J, Touzel M, Allen-Vercoe E, Alizon S, Froissart R Adv Ecol Res. 2024; 57:201-281.

PMID: 39404686 PMC: 7616576. DOI: 10.1016/bs.aecr.2016.11.002.


Determinants of pegivirus persistence, cross-species infection, and adaptation in the laboratory mouse.

Nennig K, Murthy S, Maloney S, Shaw T, Sharobim M, Matkovic E PLoS Pathog. 2024; 20(8):e1012436.

PMID: 39196893 PMC: 11355568. DOI: 10.1371/journal.ppat.1012436.


Co-Infections and Superinfections between HIV-1 and Other Human Viruses at the Cellular Level.

Acchioni C, Sandini S, Acchioni M, Sgarbanti M Pathogens. 2024; 13(5).

PMID: 38787201 PMC: 11124504. DOI: 10.3390/pathogens13050349.


The Blood Virome: A new frontier in biomedical science.

Kandathil A, Thomas D Biomed Pharmacother. 2024; 175:116608.

PMID: 38703502 PMC: 11184943. DOI: 10.1016/j.biopha.2024.116608.